Nisa Investment Advisors, LLC Aquestive Therapeutics, Inc. Transaction History
Nisa Investment Advisors, LLC
- $19.6 Billion
- Q1 2025
A detailed history of Nisa Investment Advisors, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 101 shares of AQST stock, worth $296. This represents 0.0% of its overall portfolio holdings.
Number of Shares
101
Previous 189
46.56%
Holding current value
$296
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AQST
# of Institutions
124Shares Held
43.5MCall Options Held
504KPut Options Held
148K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$28.8 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$16 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$12.8 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.63MShares$7.73 Million1.54% of portfolio
-
Franklin Resources Inc San Mateo, CA2.13MShares$6.28 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $157M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...